PRPS1 mutations: four distinct syndromes and potential treatment.
Phosphoribosylpyrophosphate synthetases (PRSs) catalyze the first step of nucleotide synthesis. Nucleotides are central to cell function, being the building blocks of nucleic acids and serving as cofactors in cellular signaling and metabolism. With this in mind, it is remarkable that mutations in phosphoribosylpyrophosphate synthetase 1 (PRPS1), which is the most ubiquitously expressed gene of the three PRS genes, are compatible with life. Mutations described thus far in PRPS1 are all missense mutations that result in PRS-I superactivity or in variable levels of decreased activity, resulting in X-linked Charcot-Marie-Tooth disease-5 (CMTX5), Arts syndrome, and X-linked nonsyndromic sensorineural deafness (DFN2). Patients with PRS-I superactivity primarily present with uric acid overproduction, mental retardation, ataxia, hypotonia, and hearing impairment. Postlingual progressive hearing loss is found as an isolated feature in DFN2 patients. Patients with CMTX5 and Arts syndrome have peripheral neuropathy, including hearing impairment and optic atrophy. However, patients with Arts syndrome are more severely affected because they also have central neuropathy and an impaired immune system. The neurological phenotype in all four PRPS1-related disorders seems to result primarily from reduced levels of GTP and possibly other purine nucleotides including ATP, suggesting that these disorders belong to the same disease spectrum. Preliminary results of S-adenosylmethionine (SAM) supplementation in two Arts syndrome patients show improvement of their condition, indicating that SAM supplementation in the diet could alleviate some of the symptoms of patients with PRPS1 spectrum diseases by replenishing purine nucleotides (J.C., unpublished data).
de Brouwer
Arjan P M
AP
Department of Human Genetics, Nijmegen Centre for Molecular Life Sciences and Institute of Genetic and Metabolic Diseases, Radboud University Nijmegen Medical Centre, 6500 HB Nijmegen, The Netherlands. a.debrouwer@antrg.umcn.nl
van Bokhoven
Hans
H
Nabuurs
Sander B
SB
Arts
Willem Frans
WF
Christodoulou
John
J
Duley
John
J
D006801:Humans; D009154:Mutation / Q000235:genetics*; D010523:Peripheral Nervous System Diseases / Q000235:genetics* / Q000628:therapy*; D012268:Ribose-Phosphate Pyrophosphokinase / Q000235:genetics*; D013577:Syndrome
C510474:PRPS1 protein, human; D012268:Ribose-Phosphate Pyrophosphokinase
J Biol Chem. 1980 Jun 10;255(11):5264-9
6246102
Eur J Pediatr. 1984 Feb;141(4):208-14
6734669
Am J Hum Genet. 2005 Apr;76(4):572-80
15706485
J Biol Chem. 1981 Feb 25;256(4):1839-45
6257688
Arthritis Rheum. 1986 Jul;29(7):880-8
3017368
Am J Hum Genet. 2007 Sep;81(3):507-18
17701896
Lancet. 1992 Nov 7;340(8828):1167-8
1359249
Trends Cell Biol. 2007 Mar;17(3):118-26
17197185
Arthritis Rheum. 2003 Jul;48(7):2036-41
12847698
Neurochem Res. 1983 Nov;8(11):1451-7
6656991
Biochem Med. 1972 Aug;6(4):310-6
4340256
Nat Struct Mol Biol. 2006 Jan;13(1):13-21
16369484
Biochim Biophys Acta. 1986 Jun 19;882(2):168-76
2423135
Adv Exp Med Biol. 1989;253A:67-71
2516409
Curr Opin Genet Dev. 2006 Jun;16(3):260-9
16647850
RNA. 2004 Aug;10(8):1174-7
15272117
J Biol Chem. 1994 Mar 18;269(11):8334-40
8132556
Am J Clin Nutr. 2002 Nov;76(5):1151S-7S
12418493
J Biol Chem. 1966 Oct 25;241(20):4802-9
5926184
Adv Enzyme Regul. 1995;35:229-49
7572345
Genome Biol. 2006;7(4):R27
16594986
Ann Hum Genet. 2008 May;72(Pt 3):416-41
18215208
Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):6062-7
15075390
J Clin Invest. 2002 Aug;110(3):395-402
12163459
Am J Hum Genet. 2007 Jul;81(1):158-64
17564972
J Biol Chem. 1974 Jan 10;249(1):291-6
4358634
Neurology. 1967 Sep;17(9):827-32
6069085
Adv Exp Med Biol. 1991;309B:125-8
1664177
Biochem J. 2005 Oct 15;391(Pt 2):239-47
15943588
Nature. 2004 Nov 11;432(7014):226-30
15538371
J Biol Chem. 1958 Aug;233(2):451-5
13563519
Prog Nucleic Acid Res Mol Biol. 2001;69:115-48
11550793
Annu Rev Cell Dev Biol. 2002;18:601-35
12142283
J Pediatr. 1969 Jan;74(1):20-7
5782823
J Rheumatol. 1981 Jul-Aug;8(4):563-74
6271966
Biochem J. 2002 Aug 15;366(Pt 1):265-72
11996669
Science. 1998 Jun 26;280(5372):2074-5
9669963
Ann Neurol. 1993 May;33(5):535-9
8498830
Hum Genet. 1996 Nov;98(5):513-7
8882866
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2006 May 1;62(Pt 5):432-4
16682768
Genome Res. 2004 Sep;14(9):1741-8
15310658
J Inherit Metab Dis. 2006 Oct;29(5):687
16906475
Prog Neurobiol. 2001 Dec;65(6):593-608
11728645
J Clin Invest. 1995 Nov;96(5):2133-41
7593598
Proc Natl Acad Sci U S A. 1996 May 28;93(11):5539-43
8643611
Science. 1998 Jan 23;279(5350):509-14
9438836
Lipids. 1997 Apr;32(4):351-8
9113621
Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):14789-94
12397173
Science. 2007 Feb 23;315(5815):1137-40
17322061
J Med Genet. 2007 May;44(5):327-33
17220215
Adv Enzyme Regul. 1972;10:3-16
4569540
J Biol Chem. 1973 Feb 10;248(3):1063-73
4346344
J Biol Chem. 1958 Aug;233(2):493-500
13563527
J Recept Signal Transduct Res. 2004 Aug;24(3):165-205
15521361
Neuropediatrics. 1985 May;16(2):106-8
2989725
Lancet. 1975 May 3;1(7914):1010-3
48676
J Biol Chem. 1955 Jul;215(1):389-402
14392173
Adv Exp Med Biol. 2000;486:5-10
11783526
Am J Otol. 1999 Sep;20(5):621-6
10503584
Am J Hum Genet. 2007 Sep;81(3):552-8
17701900
J Biol Chem. 1975 Sep 10;250(17):6822-30
169259
J Physiol. 1993 Aug;468:311-24
8254512
J Pediatr. 1969 Nov;75(5):885-91
5347440
J Biol Chem. 1996 Aug 16;271(33):19894-9
8702702
J Genet. 2004 Apr;83(1):35-8
15240907
Hum Mol Genet. 1996 Dec;5(12):2055-60
8968763
J Biol Chem. 1999 Mar 12;274(11):7482-8
10066814
Neurology. 2005 Jun 14;64(11):1964-7
15955956
N Engl J Med. 1996 Jun 13;334(24):1568-72
8628337
J Lab Clin Med. 1982 Apr;99(4):495-511
6174658
Biochem Pharmacol. 1992 May 28;43(10):2053-7
1599494
Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4234-9
15024124
Am J Med. 1988 Sep;85(3):383-90
2843048
Rev Eur Etud Clin Biol. 1972 Aug-Sep;17(7):703-6
4346548
Nucleic Acids Res. 2000 Jan 1;28(1):27-30
10592173
Am J Physiol. 1980 Aug;239(2):H212-9
7406058
N Engl J Med. 1983 Mar 24;308(12):700-4
6828110
Biochem J. 2007 Jan 1;401(1):39-47
16939420
Am J Hum Genet. 2010 Jan;86(1):65-71
20021999
J Clin Invest. 1968 Oct;47(10):2281-9
5676523
Nat Rev Immunol. 2008 Jun;8(6):421-34
18483500
J Biol Chem. 1971 Sep 25;246(18):5739-48
4328836
J Clin Invest. 1975 Nov;56(5):1093-9
171280
N Engl J Med. 1981 Nov 5;305(19):1106-11
6117011
J Biol Chem. 1955 Jul;215(1):403-51
14392174
Int J Biochem Cell Biol. 2002 Jul;34(7):731-45
11950591
Nature. 2005 Mar 17;434(7031):400-4
15772666
Mol Genet Metab. 2005 Sep-Oct;86(1-2):25-33
16176880
J Clin Invest. 1980 Jan;65(1):109-20
6243137
Nat Struct Biol. 2000 Apr;7(4):303-8
10742175
J Clin Invest. 1976 Feb;57(2):308-18
176178